Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.36% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.08% |
| 4 | Healthcare | 0.89% |
| 5 | Communication Services | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
POL
11576
CALL
DELISTED
Polished.com Inc.
POL
| $17.3K | ﹤0.01% |
4,336
| – | – |
|
|
GRTX
11577
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $17.3K | ﹤0.01% |
98,543
+23,175
| +31% | +$28.8K |
|
|
CREG
11578
DELISTED
Smart Powerr
CREG
| $17.2K | ﹤0.01% |
+138
| New | +$17.6K |
|
11579
Adicet Bio
ACET
$84.3M
| $17.1K | ﹤0.01% |
781
-1,894
| -71% | -$66.9K |
|
11580
CALL
Lineage Cell Therapeutics
LCTX
$286M
| $17.1K | ﹤0.01% |
+14,500
| New | +$19.7K |
|
11581
NextCure
NXTC
$27.1M
| $16.9K | ﹤0.01% |
1,091
-2,182
| -67% | -$41.6K |
|
11582
AgEagle Aerial Systems
UAVS
$67.9M
| $16.8K | ﹤0.01% |
100
-1
| -1% | -$206 |
|
|
XNET
11583
PUT
Xunlei
XNET
$323M
| $16.7K | ﹤0.01% |
+10,400
| New | +$18.8K |
|
|
VIOT
11584
Viomi Technology
VIOT
$51.3M
| $16.7K | ﹤0.01% |
16,555
-12,775
| -44% | -$11.8K |
|
|
AIFF
11585
Firefly Neuroscience
AIFF
$16.2M
| $16.7K | ﹤0.01% |
2,227
+1,118
| +101% | +$11.4K |
|
|
STEX
11586
CALL
Streamex Corp
STEX
$88.2M
| $16.7K | ﹤0.01% |
3,400
-6,790
| -67% | -$51K |
|
11587
Serina Therapeutics
SER
$68.6M
| $16.5K | ﹤0.01% |
690
-551
| -44% | -$14.6K |
|
11588
CALL
BARK
BARK
$93.4M
| $16.4K | ﹤0.01% |
685
+45
| +7% | +$1.25K |
|
|
ZYNE
11589
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $16.4K | ﹤0.01% |
+12,900
| New | +$11.3K |
|
|
GRRR
11590
CALL
Gorilla Technology Group
GRRR
$386M
| $16.4K | ﹤0.01% |
+1,880
| New | +$37.9K |
|
11591
CALL
CEL-SCI Corp
CVM
$26M
| $16.3K | ﹤0.01% |
433
-2,414
| -85% | -$115K |
|
11592
Alaunos Therapeutics
TCRT
$4.55M
| $16.2K | ﹤0.01% |
818
-2,442
| -75% | -$105K |
|
11593
Asia Pacific Wire & Cable
APWC
$58.6M
| $16.2K | ﹤0.01% |
+11,629
| New | +$20.3K |
|
11594
CALL
Gold Royalty Corp
GROY
$816M
| $16.1K | ﹤0.01% |
12,600
-31,400
| -71% | -$49.7K |
|
11595
Clene
CLNN
$57M
| $16K | ﹤0.01% |
1,617
-406
| -20% | -$5.63K |
|
|
QVCGA
11596
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $15.9K | ﹤0.01% |
522
-72
| -12% | -$3.04K |
|
|
AMTD
11597
AMTD IDEA Group
AMTD
$73.1M
| $15.9K | ﹤0.01% |
+4,306
| New | +$18K |
|
|
BHIL
11598
DELISTED
Benson Hill, Inc.
BHIL
| $15.6K | ﹤0.01% |
1,341
-6,772
| -83% | -$211K |
|
11599
PUT
SelectQuote
SLQT
$96.7M
| $15.4K | ﹤0.01% |
13,200
-5,500
| -29% | -$8.3K |
|
11600
CALL
Microbot Medical
MBOT
$101M
| $15.4K | ﹤0.01% |
+11,100
| New | +$24.1K |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.